Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56M
-
Number of holders
-
242
-
Total 13F shares, excl. options
-
56.9M
-
Shares change
-
+1.16M
-
Total reported value, excl. options
-
$1.71B
-
Value change
-
+$26M
-
Put/Call ratio
-
0.14
-
Number of buys
-
116
-
Number of sells
-
-125
-
Price
-
$30.06
Significant Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q2 2023
287 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q2 2023.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 242 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.9M shares
.
Largest 10 shareholders include BlackRock Inc. (9.96M shares), VANGUARD GROUP INC (6.04M shares), ARMISTICE CAPITAL, LLC (5.04M shares), MACQUARIE GROUP LTD (2.5M shares), DIMENSIONAL FUND ADVISORS LP (2.43M shares), STATE STREET CORP (1.87M shares), Stephens Investment Management Group LLC (1.7M shares), LOOMIS SAYLES & CO L P (1.59M shares), Polar Capital Holdings Plc (1.5M shares), and RENAISSANCE TECHNOLOGIES LLC (1.5M shares).
This table shows the top 242 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.